GlassScriptPhysician profile
David Werth Barry
NPI 1427222819
$561.14
in general payments reported to CMS, 2019-2025
11 companies · $28.85 in 2025
The $28.85 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.74 · 2020: $150 · 2021: $88.70 · 2022: $101 · 2023: $110 · 2024: $18.00 · 2025: $28.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $156.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Healthcare Americas Corporation | $240.69 | 2020-2022 | |
| Abbvie INC. | $119.75 | 2021-2023 | Viberzi, Linzess |
| Qol Medical, LLC | $53.11 | 2019 | |
| Celgene Corporation | $30.95 | 2022-2024 | Zeposia |
| Gilead Sciences, INC. | $28.85 | 2025 | |
| Coala Life INC | $25.99 | 2023 | Coala Heart Monitor |
| Organon LLC | $16.98 | 2023 | Hadlima |
| Merck Sharp & Dohme LLC | $14.96 | 2023 | Dificid |
| Pfizer INC. | $13.02 | 2023 | |
| Shionogi INC | $11.63 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $5.21 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.